Search

Cecile H. Vo

Examiner (ID: 6019, Phone: (571)270-3031 , Office: P/2153 )

Most Active Art Unit
2153
Art Unit(s)
2153, 2169
Total Applications
495
Issued Applications
315
Pending Applications
30
Abandoned Applications
158

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7126966 [patent_doc_number] => 20050058710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Porous drug matrices and methods of manufacture thereof' [patent_app_type] => utility [patent_app_number] => 10/928886 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10762 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20050058710.pdf [firstpage_image] =>[orig_patent_app_number] => 10928886 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/928886
Porous drug matrices and methods of manufacture thereof Aug 26, 2004 Abandoned
Array ( [id] => 185156 [patent_doc_number] => 07648982 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-19 [patent_title] => 'Opioid delivery system' [patent_app_type] => utility [patent_app_number] => 10/927145 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 28 [patent_no_of_words] => 17446 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 288 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/648/07648982.pdf [firstpage_image] =>[orig_patent_app_number] => 10927145 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/927145
Opioid delivery system Aug 26, 2004 Issued
Array ( [id] => 876370 [patent_doc_number] => 07358226 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-15 [patent_title] => 'Ultrasonic concentration of drug delivery capsules' [patent_app_type] => utility [patent_app_number] => 10/928648 [patent_app_country] => US [patent_app_date] => 2004-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 19 [patent_no_of_words] => 21094 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358226.pdf [firstpage_image] =>[orig_patent_app_number] => 10928648 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/928648
Ultrasonic concentration of drug delivery capsules Aug 25, 2004 Issued
Array ( [id] => 7436350 [patent_doc_number] => 20040266869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Novel medicament compositions based on anticholinesterase drugs and on ciclesonides' [patent_app_type] => new [patent_app_number] => 10/465921 [patent_app_country] => US [patent_app_date] => 2004-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7380 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266869.pdf [firstpage_image] =>[orig_patent_app_number] => 10465921 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/465921
Novel medicament compositions based on anticholinesterase drugs and on ciclesonides Aug 25, 2004 Abandoned
Array ( [id] => 6966002 [patent_doc_number] => 20050232899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b' [patent_app_type] => utility [patent_app_number] => 10/927518 [patent_app_country] => US [patent_app_date] => 2004-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9920 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232899.pdf [firstpage_image] =>[orig_patent_app_number] => 10927518 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/927518
Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b Aug 24, 2004 Abandoned
Array ( [id] => 7175803 [patent_doc_number] => 20050123486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Medical product containing tiotropium' [patent_app_type] => utility [patent_app_number] => 10/921192 [patent_app_country] => US [patent_app_date] => 2004-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8686 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20050123486.pdf [firstpage_image] =>[orig_patent_app_number] => 10921192 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/921192
Medical product containing tiotropium Aug 18, 2004 Abandoned
Array ( [id] => 7026459 [patent_doc_number] => 20050020502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Sincalide formulations' [patent_app_type] => utility [patent_app_number] => 10/921732 [patent_app_country] => US [patent_app_date] => 2004-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15539 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020502.pdf [firstpage_image] =>[orig_patent_app_number] => 10921732 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/921732
Sincalide formulations Aug 18, 2004 Abandoned
Array ( [id] => 5590418 [patent_doc_number] => 20060039869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Intranasal delivery of antipsychotic drugs' [patent_app_type] => utility [patent_app_number] => 10/920153 [patent_app_country] => US [patent_app_date] => 2004-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4299 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20060039869.pdf [firstpage_image] =>[orig_patent_app_number] => 10920153 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/920153
Intranasal delivery of antipsychotic drugs Aug 16, 2004 Abandoned
Array ( [id] => 7249098 [patent_doc_number] => 20040258623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Insulin-containing oral spray and the preparation method thereof' [patent_app_type] => new [patent_app_number] => 10/486461 [patent_app_country] => US [patent_app_date] => 2004-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2942 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20040258623.pdf [firstpage_image] =>[orig_patent_app_number] => 10486461 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/486461
Insulin-containing oral spray and the preparation method thereof Aug 12, 2004 Abandoned
Array ( [id] => 7265099 [patent_doc_number] => 20040242635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Encapsulated dyes in cosmetic compositions' [patent_app_type] => new [patent_app_number] => 10/432762 [patent_app_country] => US [patent_app_date] => 2004-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1918 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242635.pdf [firstpage_image] =>[orig_patent_app_number] => 10432762 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/432762
Encapsulated dyes in cosmetic compositions Aug 5, 2004 Abandoned
Array ( [id] => 363186 [patent_doc_number] => 07481996 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-27 [patent_title] => 'Aerosol cosmetic composition' [patent_app_type] => utility [patent_app_number] => 10/911488 [patent_app_country] => US [patent_app_date] => 2004-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7111 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 323 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/481/07481996.pdf [firstpage_image] =>[orig_patent_app_number] => 10911488 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/911488
Aerosol cosmetic composition Aug 4, 2004 Issued
Array ( [id] => 7199856 [patent_doc_number] => 20050042179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Inhalative powder formulations containing the CGRP-antagonist 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine' [patent_app_type] => utility [patent_app_number] => 10/909619 [patent_app_country] => US [patent_app_date] => 2004-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3872 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042179.pdf [firstpage_image] =>[orig_patent_app_number] => 10909619 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/909619
Inhalative powder formulations containing the CGRP-antagonist 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine Aug 1, 2004 Abandoned
Array ( [id] => 7199858 [patent_doc_number] => 20050042180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Powder formulation containing the CGRP antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2 (1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin, process for preparing and the use thereof as inhalation powder' [patent_app_type] => utility [patent_app_number] => 10/909624 [patent_app_country] => US [patent_app_date] => 2004-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5440 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042180.pdf [firstpage_image] =>[orig_patent_app_number] => 10909624 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/909624
Powder formulation containing the CGRP antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2 (1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin, process for preparing and the use thereof as inhalation powder Aug 1, 2004 Abandoned
Array ( [id] => 7127899 [patent_doc_number] => 20050059643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Medicaments for inhalation comprising a steroid and a betamimetic' [patent_app_type] => utility [patent_app_number] => 10/903769 [patent_app_country] => US [patent_app_date] => 2004-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7470 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059643.pdf [firstpage_image] =>[orig_patent_app_number] => 10903769 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/903769
Medicaments for inhalation comprising a steroid and a betamimetic Jul 29, 2004 Abandoned
Array ( [id] => 7159422 [patent_doc_number] => 20050084457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Capsules containing inhalable tiotropium' [patent_app_type] => utility [patent_app_number] => 10/901790 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6565 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20050084457.pdf [firstpage_image] =>[orig_patent_app_number] => 10901790 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/901790
Capsules containing inhalable tiotropium Jul 28, 2004 Abandoned
Array ( [id] => 7199853 [patent_doc_number] => 20050042178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder' [patent_app_type] => utility [patent_app_number] => 10/901791 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4905 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042178.pdf [firstpage_image] =>[orig_patent_app_number] => 10901791 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/901791
Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder Jul 28, 2004 Abandoned
Array ( [id] => 7206293 [patent_doc_number] => 20050043247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative' [patent_app_type] => utility [patent_app_number] => 10/902305 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4166 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043247.pdf [firstpage_image] =>[orig_patent_app_number] => 10902305 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/902305
Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative Jul 28, 2004 Abandoned
Array ( [id] => 7192745 [patent_doc_number] => 20050163725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Method for administration of growth hormone via pulmonary delivery' [patent_app_type] => utility [patent_app_number] => 10/900992 [patent_app_country] => US [patent_app_date] => 2004-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5607 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20050163725.pdf [firstpage_image] =>[orig_patent_app_number] => 10900992 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/900992
Method for administration of growth hormone via pulmonary delivery Jul 27, 2004 Abandoned
Array ( [id] => 860456 [patent_doc_number] => 07371727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-13 [patent_title] => 'Methods and compositions for the treatment of gastrointestinal disorders' [patent_app_type] => utility [patent_app_number] => 10/899806 [patent_app_country] => US [patent_app_date] => 2004-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 33985 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371727.pdf [firstpage_image] =>[orig_patent_app_number] => 10899806 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/899806
Methods and compositions for the treatment of gastrointestinal disorders Jul 26, 2004 Issued
Array ( [id] => 7199852 [patent_doc_number] => 20050042177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Novel compositions of sildenafil free base' [patent_app_type] => utility [patent_app_number] => 10/895405 [patent_app_country] => US [patent_app_date] => 2004-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17297 [patent_no_of_claims] => 107 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042177.pdf [firstpage_image] =>[orig_patent_app_number] => 10895405 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/895405
Novel compositions of sildenafil free base Jul 20, 2004 Abandoned
Menu